X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $127.46 million. The enterprise value is $104.87 million.
| Market Cap | 127.46M |
| Enterprise Value | 104.87M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 167.94 million shares outstanding. The number of shares has increased by 37.01% in one year.
| Shares Outstanding | 167.94M |
| Shares Change (YoY) | +37.01% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 67.39% |
| Float | 127.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 5.09 |
| PB Ratio | 123.04 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.71, with a Debt / Equity ratio of 56.25.
| Current Ratio | 3.71 |
| Quick Ratio | 3.47 |
| Debt / Equity | 56.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.69 |
Financial Efficiency
Return on equity (ROE) is -275.40% and return on invested capital (ROIC) is -195.09%.
| Return on Equity (ROE) | -275.40% |
| Return on Assets (ROA) | -85.10% |
| Return on Capital (ROIC) | -195.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.39M |
| Employee Count | 93 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, XFOR has paid $93,000 in taxes.
| Income Tax | 93,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.30% in the last 52 weeks. The beta is 0.35, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -58.30% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 0.92 |
| Relative Strength Index (RSI) | 48.03 |
| Average Volume (20 Days) | 3,642,907 |
Short Selling Information
The latest short interest is 13.88 million, so 8.27% of the outstanding shares have been sold short.
| Short Interest | 13.88M |
| Short Previous Month | 11.92M |
| Short % of Shares Out | 8.27% |
| Short % of Float | 10.86% |
| Short Ratio (days to cover) | 5.49 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -115.71M |
| Pretax Income | -128.82M |
| Net Income | -128.91M |
| EBITDA | -120.35M |
| EBIT | -122.28M |
| Earnings Per Share (EPS) | -$0.69 |
Balance Sheet
The company has $80.87 million in cash and $58.28 million in debt, giving a net cash position of $22.59 million or $0.13 per share.
| Cash & Cash Equivalents | 80.87M |
| Total Debt | 58.28M |
| Net Cash | 22.59M |
| Net Cash Per Share | $0.13 |
| Equity (Book Value) | 1.04M |
| Book Value Per Share | 0.01 |
| Working Capital | 63.79M |
Cash Flow
In the last 12 months, operating cash flow was -$103.60 million and capital expenditures -$110,000, giving a free cash flow of -$103.71 million.
| Operating Cash Flow | -103.60M |
| Capital Expenditures | -110,000 |
| Free Cash Flow | -103.71M |
| FCF Per Share | -$0.52 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -37.01% |
| Shareholder Yield | -37.01% |
| Earnings Yield | -101.14% |
| FCF Yield | -81.36% |
Analyst Forecast
The average price target for XFOR is $3.67, which is 383.53% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.67 |
| Price Target Difference | 383.53% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 14, 2019. It was a reverse split with a ratio of 1:6.
| Last Split Date | Mar 14, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |